Assessing Patients with Unexplained LVH: Walkthrough of a Complex Case
With rare diseases, like Fabry disease, the patient’s journey from experiencing their first symptoms to getting a proper diagnosis can be a long and tiresome cycle of investigations.
Cardiologists can play a key role identifying early signs of rare diseases, which can ultimately lead to an earlier diagnosis for the patient.
To learn more participate in the accredited CME: A Practical Approach to the Diagnosis of Unexplained LVH: Insights into Infiltrative Cardiomyopathies
This program has received an educational grant or in-kind support from Sanofi Genzyme.
Gavin Y Oudit, MD, PhD, FRCPC
Amelia Yip, MD, FRCPC
Upon completion of this program, participants will be better able to:
- Develop a structured approach to the diagnosis of patients with unexplained LVH
- Identify symptoms and imaging results that will help guide clinicians towards a diagnosis in patients with unexplained LVH